Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue Estimates
CTKBCYTEK(CTKB) ZACKS·2024-08-07 07:22

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of 0.08pershareversustheZacksConsensusEstimateofalossof0.08 per share versus the Zacks Consensus Estimate of a loss of 0.03. This compares to earnings of 0.01pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−166.670.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -166.67%. A quarter ago, it was expected that this company would post a loss of 0.05 per share when it actually produced a loss of $0.05, delivering no surprise.Over the last four quarters, the company has sur ...